BlackThorn Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- BlackThorn Therapeutics's estimated annual revenue is currently $155k per year.
- BlackThorn Therapeutics's estimated revenue per employee is $77,500
- BlackThorn Therapeutics's total funding is $138M.
Employee Data
- BlackThorn Therapeutics has 2 Employees.
- BlackThorn Therapeutics grew their employee count by 0% last year.
BlackThorn Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Chair | Reveal Email/Phone |
BlackThorn Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BlackThorn Therapeutics?
BlackThorn Therapeutics is a neurobehavioral health company developing targeted therapeutics, informed by a deep understanding of brain and behavior relationships, to significantly improve patient outcomes. The company has pioneered a proprietary computational psychiatry platform, which leverages bioinformatics, neuroinformatics and artificial intelligence technologies, with the goal of determining a patient's distinct neuroprint to inform the proper on-target treatment option for biologically defined patient subtypes. BlackThorn Therapeutics has completed a Phase 1 trial of BTRX-335140, a selective kappa opioid receptor antagonist, and is conducting IND-enabling studies for BTRX-323511, a selective vasopressin 1a receptor antagonist. The company also has a drug discovery program directed at novel therapeutic targets for neurobehavioral disorders. BlackThorn Therapeutics is headquartered in San Francisco, California. For more information, please visit http://www.blackthornrx.com.
keywords:N/A
$138M
Total Funding
2
Number of Employees
$155k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BlackThorn Therapeutics News
Few biotechs start life with as strong a hand as Neumora Therapeutics. Having struck a deal with Amgen and rolled up biotechs including BlackThorn Therapeutics,...
For example, BlackThorn Therapeutics (now part of Neumora Therapeutics), a clinical-stage neurobehavioral health company,...
Clinical-stage neurobehavioral health company BlackThorn Therapeutics announced it raised $76 million in Series B funding BlackThorn Therapeutics is a clinical-stage neurobehavioral health company that is pioneering next-generation artificial intelligence (AI) technologies to advance targeted t ...
There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its technological approach to finding drugs that work will p ...
BlackThorn Therapeutics, a San Francisco, California-based clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics, closed a $76m Series B financing. New investors, including Polaris Partners, Premier P ...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 2 | 0% | N/A |
#2 | $128.2M | 2 | 0% | $138.2M |
#3 | $0M | 2 | 0% | $2.6M |
#4 | $0M | 2 | 0% | $3M |
#5 | $0M | 2 | -50% | N/A |